Accellacare-DuPage Medical Group — Raleigh, North Carolina

Accellacare-DuPage Medical Group is a clinical research site located in Raleigh, North Carolina, United States 27609.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Accellacare-DuPage Medical Group has participated in 1 clinical trials.

Therapeutic areas: Upper Tract Urothelial Carcinomas, Urothelial Bladder Cancer.

Sponsors: QED Therapeutics, a BridgeBio company.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Accellacare-DuPage Medical Group?

Accellacare-DuPage Medical Group has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Accellacare-DuPage Medical Group conducted?

Accellacare-DuPage Medical Group has 1 clinical trials on record. Their work covers Upper Tract Urothelial Carcinomas, Urothelial Bladder Cancer.

Is Accellacare-DuPage Medical Group accredited by Crixeo Health?

Accellacare-DuPage Medical Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Accellacare-DuPage Medical Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.